Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage

Journal of Hypertension

Volumn 23, Issue 1, 2005, Pages 133-140

  Strain, William D ^a   Chaturvedi, Nish ^a   Leggetter, Sandra ^a   Nihoyannopoulos, Petros ^b   Rajkumar, Chakravarthi ^a   Bulpitt, Christopher J ^a   Shore, Angela C ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Afro Caribbeans; Epidemiology; Ethnicity; Left ventricular hypertrophy; Microvascular

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CARIBBEAN ISLANDS; ECHOCARDIOGRAPHY; ETHNOLOGY; EUROPE; FEMALE; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEATING; HUMAN; HYPERTENSION; ISCHEMIA; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; ORGAN INJURY; PRIORITY JOURNAL; RISK FACTOR; SKIN BLOOD FLOW; TARGET ORGAN; UNITED KINGDOM; VASCULAR RESISTANCE;

EID: 12344282760     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200501000-00023     Document Type: Article

References (38)

1. Chaturvedi N, McKeigue PM, Marmot MG. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension 1993; 22:90-96.
2. Chaturvedi N, Athanassopoulos G, McKeigue PM, Marmot MG, Nihoyannopoulos P. Echocardiographic measures of left ventricular structure and their relationship with resting and ambulatory blood pressure in Afro-Caribbeans and Europeans in the UK. J Am Coll Cardiol 1994; 24:1499-1505.
3. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988; 12:285-290.
4. Aalkjaer C, Heagerty AM, Peterson KK, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake and decreased excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
5. Sivertsson R, Hansson L. Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. Clin Sci Moll Med 1976; 51(suppl):77S-79S.
6. Williams SA, Tooke JE. Noninvasive estimation of increased structurally-based resistance to blood flow in the skin of subjects with essential hypertension. Int J Microcirc Clin Exp 1992; 11:109-116.
7. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99:1873-1879.
8. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33:998-1001.
9. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wasserman SM, Tooke JE. Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci (Lond) 1990; 79:5-8.
10. Michel CC, Neal CR. Openings through endothelial cells associated with increased microvascular permeability. Microcirculation 1999; 6:45-54.
11. Riser BL, Cortes P, Zhao X, Bernstein J, Dumler F, Narins RG. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90:1932-1943.
12. Cheng JJ, Wung BS, Chao YJ, Wang DL. Cyclic strain enhances adhesion of monocytes to endothelial cells by increasing intercellular adhesion molecule-1 expression. Hypertension 1996; 28:386-391.
13. Wang DS, Proffit D, Tsao PS. Mechanotransduction of endothelial oxidative stress induced by cyclic strain. Endothelium 2001; 8:283-291.
14. Weinberger MH, Fineberg NS, Fineberg SE. Effects of age, race, gender, blood pressure, and estrogen on arterial compliance. Am J Hypertens 2002; 15:358-363.
15. Prisant LM, Resnick LM, Hollenberg SM, Jupin D. Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects: influence of race. Ethn Dis 2002; 12:63-68.
16. Kahn DF, Duffy SJ, Tomasian D, Holbrook M, Rescorl L, Russell J, et al. Effects of black race on forearm resistance vessel function. Hypertension 2002; 40:195-201.
17. Hansen PR, Haunso S. Effects of nitric oxide synthase inhibition on myocardial capillary permeability and reactive hyperaemic response. Cardiovasc Res 1995; 29:862-866.
18. Bottcher M, Madsen MM, Refsgaard J, Buus NH, Dorup I, Nielsen TT, Sorensen K. Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve. Circulation 2001; 103:1109-1114.
19. Branten AJ, Smits P, Jansen TL, Wollersheim H, Thien T. Effect of atrial natriuretic factor on skin microcirculation versus skeletal muscle blood flow. J Cardiovasc Pharmacol 1996; 27:303-306.
20. Ijzerman RG, de Jongh RT, Beijk MA, van Weissenbruch MM, Delemarrevan de Waal HA, Serne EH, Stehouwer CD. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003; 33:536-542.
21. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002; 288:67-74.
22. Bone M. Registration with general medical practitioners in Inner London: a survey carried out on behalf of the Department of Health and Social Security. London: HMSO; 1984.
23. Akinkugbe OO. World epidemiology of hypertension in blacks. In: Hall WD, Saunders E, Shulman NB (editors): Hypertension in blacks. Chicago: Year Book Medical Publishers Inc.; 1985. pp. 3-16.
24. Chaturvedi N, McKeigue PM, Marmot MG. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 1994; 37:765-772.
25. Devereux RB, Liebson PR, Horan MJ. Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987; 9(suppl II):97-104.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
27. Cupples LA, Heeren T, Schatzkin A, Colton T. Multiple testing of hypotheses in comparing two groups. Ann Intern Med 1984; 100: 122-129.
28. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1:43-46.
29. Tooke JE, Morris SJ, Shore AC. Microvascular functional abnormalities in diabetes: the role of the endothelium. Diabetes Res Clin Pract 1996; 31(suppl):S127-S132.
30. Morris SJ, Kunzek S, Shore AC. The effect of acetylcholine on finger capillary pressure and capillary flow in healthy volunteers. J Physiol 1996; 494:307-313.
31. Boegehold MA. Microvascular structure and function in salt-sensitive hypertension. Microcirculation 2002; 9:225-241.
32. Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 2003; 89:175-178.
33. Hana V, Prazny M, Marek J, Skrha J, Justova V. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement. Eur J Endocrinol 2002; 147:333-337.
34. Jaap AJ, Pym CA, Seamark C, Shore AC, Tooke JE. Microvascular function in type 2 (non-insulin-dependent) diabetes: improved vasodilation after one year of good glycaemic control. Diabet Med 1995; 12: 1086-1091.
35. Serne EH, Stehouwer CD, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJ, Gans RO. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999; 99:896-902.
36. Shimizu M, Pelisek J, Nikol S. Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree. Curr Med Chem 2002; 9:1619-1630.
37. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
38. Mulvany MJ. Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients. Metabolism 1998; 47:20-23.